Benvenue Medical touts 12-month data from lumbar fusion study
[Image from Benvenue Medical]
The clinical results showed improved back and leg pain relief and lowered Oswestry Disability Index scores 12 months post-operation with the Luna expandable Transforaminal Lumbar Interbody Fusion cage.
Single-center data from 47 consecutive MIS TLIF patients showed that lordosis was maintained or improved equally using the Luna lordotic and parallel cages. Back pain and leg pain were equally relieved using both cages and had a fusion rate of 95%.
“The Luna data shows an excellent correction of disc space height and foraminal height,” Dr. Richard Fessler, who completed the study, said in a news release. “There was a strong correlation between that correction and clinical outcomes. It’s the most exciting interbody device that I’ve seen in my career – it can be put in through a TLIF exposure but expands into ALIF coverage. It achieves both of my surgical goals of being minimally invasive and offering maximal coverage.”
The Luna system is a small, multi-expandable interbody fusion device that uses ALIF principles with a controlled posterior approach to provide anterior column stability, strength and fusion support in patients who have symptomatic degenerative disc disease.
“The results from this study confirm that our Luna interbody cage provides improved outcomes for patients with degenerative disc disease,” CEO Robert Weigle said. “We are thrilled to offer an interbody cage device that utilizes the smallest incision while providing the largest implant footprint designed to afford surgeons a large graft chamber to facilitate fusion success, maximum height restoration, optimized sagittal balance and minimal subsidence with consistent deployment.”
